BG64363B1 - Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти - Google Patents

Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти Download PDF

Info

Publication number
BG64363B1
BG64363B1 BG104286A BG10428600A BG64363B1 BG 64363 B1 BG64363 B1 BG 64363B1 BG 104286 A BG104286 A BG 104286A BG 10428600 A BG10428600 A BG 10428600A BG 64363 B1 BG64363 B1 BG 64363B1
Authority
BG
Bulgaria
Prior art keywords
carnitine
alcohol
propionyl
composition
acetyl
Prior art date
Application number
BG104286A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104286A (en
Inventor
Aldo Fassi
Claudio Cavazza
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of BG104286A publication Critical patent/BG104286A/xx
Publication of BG64363B1 publication Critical patent/BG64363B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BG104286A 1997-10-03 2000-03-30 Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти BG64363B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Publications (2)

Publication Number Publication Date
BG104286A BG104286A (en) 2000-11-30
BG64363B1 true BG64363B1 (bg) 2004-12-30

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104286A BG64363B1 (bg) 1997-10-03 2000-03-30 Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans

Also Published As

Publication number Publication date
EE200000235A (et) 2001-06-15
EP1022960A1 (en) 2000-08-02
WO1999017623A1 (en) 1999-04-15
IS5416A (is) 2000-03-24
EA002177B1 (ru) 2002-02-28
EP1022960B1 (en) 2002-07-24
CZ20001207A3 (cs) 2000-11-15
KR100560097B1 (ko) 2006-03-13
NO20001688L (no) 2000-06-02
EA200000377A1 (ru) 2000-10-30
HUP0004336A2 (hu) 2001-05-28
NO20001688D0 (no) 2000-03-31
NZ503663A (en) 2001-11-30
CA2305598A1 (en) 1999-04-15
HUP0004336A3 (en) 2001-07-30
US6255346B1 (en) 2001-07-03
PL339621A1 (en) 2001-01-02
CA2305598C (en) 2007-11-20
EE04036B1 (et) 2003-06-16
BR9812604A (pt) 2000-08-01
ATE220860T1 (de) 2002-08-15
DE69806788D1 (de) 2002-08-29
MXPA00003232A (es) 2004-03-10
DK1022960T3 (da) 2002-11-04
DE69806788T2 (de) 2003-04-03
PT1022960E (pt) 2002-12-31
CZ291801B6 (cs) 2003-05-14
KR100530368B1 (ko) 2005-11-22
IT1295408B1 (it) 1999-05-12
CN1092939C (zh) 2002-10-23
JP2001518484A (ja) 2001-10-16
SK4762000A3 (en) 2000-10-09
KR20010030928A (ko) 2001-04-16
AU730740B2 (en) 2001-03-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
CN1276704A (zh) 2000-12-13
PL189663B1 (pl) 2005-09-30
UA66807C2 (uk) 2004-06-15
KR20050088499A (ko) 2005-09-06
BG104286A (en) 2000-11-30
ES2180200T3 (es) 2003-02-01
IS2234B (is) 2007-04-15
SK283384B6 (sk) 2003-06-03
ITRM970594A1 (it) 1999-04-03

Similar Documents

Publication Publication Date Title
BG64363B1 (bg) Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти
US9623073B2 (en) Learning motivation improvers
CA2314942C (en) Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
AU2015230895B2 (en) Methods and compositions for using cinnamaldehyde and zinc for weight management
US5627172A (en) Method for reduction of serum blood lipids or lipoprotein fraction
HK1028714B (en) Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects
GB2140688A (en) Fatty acid containing compositions
EP0616805B1 (en) Use of acyl L-carnitine gamma-hydroxybutyrate for the treatment of alcoholism
MXPA03009631A (es) Composicion para prevencion o tratamiento de trastornos del aprendizaje en ninos que sufren del trastorno de deficit de atencion/hiperactivo.
EP1399143B1 (en) Use of acetyl l-carnitine for the preparation of a medication to treat anhedonia
Gamaleldin et al. Nutrition and Brain Neurotransmitters
JP2004067537A (ja) 交感神経の興奮抑制剤
HK1009326B (en) Use of acyl l-carnitine gamma-hydroxybutyrate for the treatment of alcoholism
Del Piccolo et al. Rifaximin reduces EEG relative beta power in patients with minimal hepatic encephalopathy: Preliminary findings
TW200841827A (en) A nutritional supplement for adjustment of blood pressure and protection of cardio-vascular and cerebro-vascular systems
Pellegrini et al. Rifaximin reduces EEG relative beta power in patients with minimal hepatic encephalopathy: preliminary findings